French biotech Generare speeds up hunt for new drugs by cloning natural molecules

Quick Summary:

French biotech startup Generare has closed a €5 million seed round (around $5.5 million at current exchange rates) to step up development of what it touts as a highly scalable approach to identifying promising compounds for drug discovery that already exist in nature.

So what we need is, in fact, mostly a governmental answer — at the EU scale, at the US scale — that will inject some guarantee that the company that invests in R&D and antibiotics will get a return on their investment.“There’s hope,” he adds.“There’s the PASTEUR Act in the U.S.that might pass and offer this kind of guarantee, and the EU as well is working actively.

Beyond soil microbes, the startup says marine environments offer another vast hunting ground where it can apply its approach.“Really the exciting thing, in a way, is we know only 3% of all these chemicals that are made by microbes,” Libis adds.“[Humanity has] only discovered 3%… so a large reservoir still needs to be explored.“We know that we only found 3% because we see 97% more genes than we see known molecules.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Author / Journalist: Natasha Lomas

Category: StartupsBusiness

Markets: United States

Topics: Startups Drug discovery biotech New antibiotics Generare

Source Website Secure: Yes (HTTPS)

News Sentiment: Positive

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-10-08 @ 06:00:00 (16 hours ago)

News Timezone: GMT -5:00

News Source URL: techcrunch.com

Language: English

Article Length: 1960 words

Reading Time: 11 minutes read

Sentences: 53 lines

Sentence Length: 37 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © TechCrunch

News ID: 22948711

View Article Analysis

About TechCrunch

Main Topics: StartupsBusiness

Official Website: techcrunch.com

Update Frequency: 1 posts per day

Year Established: 2005

Headquarters: United States

News Last Updated: 3 days ago

Coverage Areas: United States

Ownership: Independent Company

Publication Timezone: GMT -5:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #4

Publisher Details

Frequently Asked Questions